These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20547352)

  • 1. Efficient affinity maturation of antibodies in an engineered chicken B cell line DT40-SW by increasing point mutation.
    Kajita M; Okazawa T; Ikeda M; Todo K; Magari M; Kanayama N; Ohmori H
    J Biosci Bioeng; 2010 Sep; 110(3):351-8. PubMed ID: 20547352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of hypermutation frequency in the chicken B cell line DT40 for efficient diversification of the antibody repertoire.
    Magari M; Kanehiro Y; Todo K; Ikeda M; Kanayama N; Ohmori H
    Biochem Biophys Res Commun; 2010 May; 396(2):353-8. PubMed ID: 20416279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional transformation of immunoglobulin mutation pattern from gene conversion into point mutation by controlling XRCC3 expression in the DT40 B cell line.
    Kajita M; Magari M; Todo K; Kanayama N; Ohmori H
    J Biosci Bioeng; 2010 Apr; 109(4):407-10. PubMed ID: 20226386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Creation of valuable antibodies by an in vitro antibody generation system using a hypermutating B cell line].
    Kanayama N; Todo K; Magari M; Ohmori H
    Yakugaku Zasshi; 2009 Jan; 129(1):11-7. PubMed ID: 19122431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible switching of immunoglobulin hypermutation machinery in a chicken B cell line.
    Kanayama N; Todo K; Reth M; Ohmori H
    Biochem Biophys Res Commun; 2005 Feb; 327(1):70-5. PubMed ID: 15629431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel in vitro screening system for monoclonal antibodies using hypermutating chicken B cell library.
    Todo K; Miyake K; Magari M; Kanayama N; Ohmori H
    J Biosci Bioeng; 2006 Nov; 102(5):478-81. PubMed ID: 17189180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnology and the chicken B cell line DT40.
    Bachl J; Caldwell RB; Buerstedde JM
    Cytogenet Genome Res; 2007; 117(1-4):189-94. PubMed ID: 17675859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline variable region gene segment derivation of human monoclonal anti-Rh(D) antibodies. Evidence for affinity maturation by somatic hypermutation and repertoire shift.
    Bye JM; Carter C; Cui Y; Gorick BD; Songsivilai S; Winter G; Hughes-Jones NC; Marks JD
    J Clin Invest; 1992 Dec; 90(6):2481-90. PubMed ID: 1469099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation.
    Sale JE; Calandrini DM; Takata M; Takeda S; Neuberger MS
    Nature; 2001 Aug; 412(6850):921-6. PubMed ID: 11528482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells: LAT1 is a promising molecular target for human cancer therapy.
    Ohkawa M; Ohno Y; Masuko K; Takeuchi A; Suda K; Kubo A; Kawahara R; Okazaki S; Tanaka T; Saya H; Seki M; Enomoto T; Yagi H; Hashimoto Y; Masuko T
    Biochem Biophys Res Commun; 2011 Mar; 406(4):649-55. PubMed ID: 21371427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ex vivo method for rapid generation of monoclonal antibodies (ADLib system).
    Seo H; Hashimoto S; Tsuchiya K; Lin W; Shibata T; Ohta K
    Nat Protoc; 2006; 1(3):1502-6. PubMed ID: 17406441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible contribution of DNase gamma to immunoglobulin V gene diversification.
    Okamoto N; Okamoto M; Araki S; Arakawa H; Mizuta R; Kitamura D
    Immunol Lett; 2009 Jun; 125(1):22-30. PubMed ID: 19501119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin gene conversion: insights from bursal B cells and the DT40 cell line.
    Arakawa H; Buerstedde JM
    Dev Dyn; 2004 Mar; 229(3):458-64. PubMed ID: 14991701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic manipulation of an exogenous non-immunoglobulin protein by gene conversion machinery in a chicken B cell line.
    Kanayama N; Todo K; Takahashi S; Magari M; Ohmori H
    Nucleic Acids Res; 2006 Jan; 34(2):e10. PubMed ID: 16421270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel DT40 Antibody Library for the Generation of Monoclonal Antibodies.
    Wang B; Wang F; Huang H; Zhao Z
    Virol Sin; 2019 Dec; 34(6):641-647. PubMed ID: 31240617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and iterative affinity maturation of antibodies in vitro using hypermutating B-cell lines.
    Cumbers SJ; Williams GT; Davies SL; Grenfell RL; Takeda S; Batista FD; Sale JE; Neuberger MS
    Nat Biotechnol; 2002 Nov; 20(11):1129-34. PubMed ID: 12379869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin gene conversion in chicken DT40 cells largely proceeds through an abasic site intermediate generated by excision of the uracil produced by AID-mediated deoxycytidine deamination.
    Di Noia JM; Neuberger MS
    Eur J Immunol; 2004 Feb; 34(2):504-8. PubMed ID: 14768055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid generation of specific antibodies by enhanced homologous recombination.
    Seo H; Masuoka M; Murofushi H; Takeda S; Shibata T; Ohta K
    Nat Biotechnol; 2005 Jun; 23(6):731-5. PubMed ID: 15924134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chicken monoclonal antibody isolated by a phage display system.
    Yamanaka HI; Inoue T; Ikeda-Tanaka O
    J Immunol; 1996 Aug; 157(3):1156-62. PubMed ID: 8757621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of the somatic hypermutation process leading to antibody D1.3, a high affinity antibody directed against lysozyme.
    England P; Nageotte R; Renard M; Page AL; Bedouelle H
    J Immunol; 1999 Feb; 162(4):2129-36. PubMed ID: 9973487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.